BioMed X and Novo Nordisk Partner to Advance Oral Peptide Drug Delivery
BioMed X and Novo Nordisk’s partnership aims to address one of the most critical challenges in modern drug development: the efficient oral delivery of therapeutic peptides.
Oral Delivery Of Therapeutic Peptides | 21/08/2025 | By Dineshwori | 321
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy